154 related articles for article (PubMed ID: 21744636)
1. [Rheumatoid polyarthritis: a new treatment].
Perspect Infirm; 2010; 7(5):46-7. PubMed ID: 21744636
[No Abstract] [Full Text] [Related]
2. New therapeutic options in rheumatoid arthritis: a focus on interleukin-6 blockade.
Furfaro N
J Infus Nurs; 2011; 34(2):107-15. PubMed ID: 21399456
[TBL] [Abstract][Full Text] [Related]
3. Biologic agents for rheumatoid arthritis: 2008 and beyond.
Sweiss NJ; Hushaw LL
J Infus Nurs; 2009; 32(1 Suppl):S4-17; quiz S19-24. PubMed ID: 19142153
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for rheumatoid arthritis. Practical guidance for optimizing treatment.
Furfaro N
Adv Nurse Pract; 2008 Jan; 16(1):61-4. PubMed ID: 20014746
[No Abstract] [Full Text] [Related]
5. Anti-interleukin-6 therapy in rheumatoid arthritis.
Woodrick R; Ruderman EM
Bull NYU Hosp Jt Dis; 2010; 68(3):211-7. PubMed ID: 20969554
[TBL] [Abstract][Full Text] [Related]
6. Anti-interleukin 6: first line in rheumatoid arthritis?
Marti L; Scheinberg M
Clin Rheumatol; 2009 Aug; 28(8):877-9. PubMed ID: 19415377
[No Abstract] [Full Text] [Related]
7. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
Nagashima T; Minota S
J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
[No Abstract] [Full Text] [Related]
8. Inhibiting interleukin-6 in rheumatoid arthritis.
Choy E
Curr Rheumatol Rep; 2008 Oct; 10(5):413-7. PubMed ID: 18817647
[TBL] [Abstract][Full Text] [Related]
9. Tocilizumab (Actemra) for rheumatoid arthritis.
Med Lett Drugs Ther; 2010 Jun; 52(1340):47-8. PubMed ID: 20539266
[No Abstract] [Full Text] [Related]
10. Interleukin-6 in rheumatoid arthritis.
Nishimoto N
Curr Opin Rheumatol; 2006 May; 18(3):277-81. PubMed ID: 16582692
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
Prescrire Int; 2009 Oct; 18(103):198-201. PubMed ID: 19882783
[TBL] [Abstract][Full Text] [Related]
12. New drugs for rheumatoid arthritis.
Olsen NJ; Stein CM
N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062
[No Abstract] [Full Text] [Related]
13. Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.
Liozon E; Ouattara B; Loustaud-Ratti V; Vidal E
Scand J Rheumatol; 2007; 36(6):484-6. PubMed ID: 18092275
[No Abstract] [Full Text] [Related]
14. Dermatomyositis during adalimumab therapy for rheumatoid arthritis.
Brunasso AM; Scocco GL; Massone C
J Rheumatol; 2010 Jul; 37(7):1549-50. PubMed ID: 20595297
[No Abstract] [Full Text] [Related]
15. [Rituximab (MabThera) as treatment of active rheumatoid arthritis].
El Fassi D; Nielsen CH; Bendtzen K
Ugeskr Laeger; 2006 Nov; 168(47):4079-81. PubMed ID: 17134602
[TBL] [Abstract][Full Text] [Related]
16. FDA approves tocilizumab to treat rheumatoid arthritis.
Thompson CA
Am J Health Syst Pharm; 2010 Feb; 67(4):254. PubMed ID: 20133526
[No Abstract] [Full Text] [Related]
17. [Cutaneous rash from the use of medicine for rheumatoid arthritis].
Hannuksela M
Duodecim; 2006; 122(1):105, 111. PubMed ID: 16509198
[No Abstract] [Full Text] [Related]
18. Use of adalimumab in treatment of autoimmune sensorineural hearing loss: a word of caution.
Conway R; Khan S; Foley-Nolan D
J Rheumatol; 2011 Jan; 38(1):176; author reply 176. PubMed ID: 21196585
[No Abstract] [Full Text] [Related]
19. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
[No Abstract] [Full Text] [Related]
20. [Adverse effects of biologic agents in treatment of rheumatoid arthritis--prevention of tuberculosis].
Tomono K; Hashimoto S
Nihon Rinsho; 2005 Jan; 63 Suppl 1():573-8. PubMed ID: 15799420
[No Abstract] [Full Text] [Related]
[Next] [New Search]